Drug Discovery Reimagined: From Data to Decisions

October 6, 2026

Novartis (700 Main St. Building)

Join us in Cambridge, MA on October 6 for a premier gathering of senior leaders who are shaping the future of drug discovery. This exclusive, invite-only event, co-hosted by CAS and Novartis, is designed to foster strategic connections and share insights that are transforming the pharma and biotech industries.

Hexagon shaped overlay

Why attend?

Engage with peers: Build relationships with a select group of senior leaders from across the global pharma and biotech ecosystem.

Gain new perspectives: Explore how data and AI are reshaping drug discovery, from data strategy and target discovery to predictive safety, synthesis, and agentic workflows, and leave with a clearer view of where the field is heading.

Shape the conversation: Share your expertise and help define how the industry puts these advances to work.

‍

"I sincerely want to thank you for the invitation to the event. The content of the discussions was very interesting and enriching. The sharing of experiences seemed to me quite candid and therefore truly useful.” - 2025 CAS Innovation Summit Attendee
Conference room with audience facing a panel and large screen showing a presentation titled 'Smarter Together.'

Speakers

Bryan Harkleroad
Director of Solution Development
CAS
View profile
Irene Pak
Head of Data for Biomedical Research
Novartis
View profile
Jeremy Jenkins
US Head Discovery Sciences
Novartis
View profile
Leela Dodda
Director of AI & Computational Chemistry
Nimbus Therapeutics
View profile
Nandini Patel
Head of Chemistry
Rgneta Thrapeutics
View profile
Orr Ravitz
Senior CAS BioFinder Product Manager, CAS
View profile
Falgun Shah
Senior Director
Merck
View profile
Russ Naven
Head of Predictive Safety Data Exploration
Novartis
View profile
Matt Martin
Head of Computational Safety Sciences
Pfizer
View profile
Jonathan Grob
VP Small Molecules
Ginkgo Bioworks
View profile
Kian Tan
Director
Novartis
View profile
Connor W. Coley
Associate Professor
MIT
View profile
Lucius Kemp
Science Director
Biosero
View profile
Andrea Bortolato
VP Drug Discovery
SandboxAQ
View profile
Ashwini Ghogare
Life Science BD Leader, Frontier AI Startups
AWS
View profile
Rishi R. Gupta
Director
Novartis
View profile
Andrea Jacobs
Senior Director, Artificial Intelligence, CAS
CAS
View profile
Tim Wahlberg
Interim President
CAS
View profile
Muneto Mogi, Ph.D.
Global Head, Global Discovery Chemistry
Novartis Institutes for Biomedical Research
View profile
Mohan Rao, Ph.D.
Distinguished Scientist, Systems & Digital Toxicology
Sanofi
View profile

Agenda

Updated on Oct 20, 2026
Time
Session
Session details
No items found.

Venue and travel

Novartis (700 Main St. Building)
700 Main Street, Cambridge, MA 02139

Getting here

By air

Boston Logan (BOS) is about a 20-minute drive in moderate traffic.

By transit

Kendall/MIT or Central stations (MBTA Red Line) are each about a 10-minute walk from the venue.

By car

Drive or rideshare to 700 Main Street. See parking options below.

Parking

Hotels

Boston Marriott Cambridge

50 Broadway, Cambridge, MA 02142
13 min. (0.6 miles)

Hyatt Regency Boston/Cambridge

575 Memorial Drive, Cambridge, MA 02139
30 min. (1.3 miles)

Questions about this event?

Reach out to Jenna DiCamillo.

About CAS

CAS connects the world's scientific knowledge to accelerate breakthroughs that improve lives. We are the scientific data intelligence partner empowering global innovators to capture the promise of AI and achieve real-world results. CAS builds the world’s largest collection of scientist-curated data. That foundation underpins our portfolio of science-smart insights platforms and integrates with R&D workflows for more confident decisions and reliable predictions. As a pioneer at the intersection of scientific data and AI-driven discovery, CAS enables leaders in life sciences, chemistry, and materials with the unique capabilities and expertise that deliver transformative innovation. CAS is a division of the American Chemical Society.

About Novartis

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 304 million people worldwide.

Learn more

Raw material sourcing in chemical manufacturing: risks, causes, and actionable paths to resilience

Two people reviewing code displayed on a widescreen monitor in a modern office with large windows.

Supercharging R&D: How AI helps us to bring medicines to patients faster

Register by
September 18, 2026